drugset / Trial / NCT06272747
Study of XH-S003 in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to assess the safety, tolerability and pharmacokinetics of XH-S003 in healthy volunteers under SAD (Single ascending dose) and MAD (Multiple ascending dose) studies. In addition, this study evaluates the food effects of XH-S003.
Timeline
- Start
- 2023-07-10
- Primary completion
- 2024-07-30
- Completion
- 2024-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XH-S003 | Unknown | 25 mg | Oral |
| Subject | XH-S003 | Unknown | 100 mg | Oral |
Indications
No indication recorded.